This inventor holds 4 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Sanofi. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Niedernhausen, DE (2021)
- Frankfurt-am-Main, DE (2023 - 2024)
Company Filing History:
Years Active: 2021-2024
Title: Wulf-Dirk Leuschner: Innovator in Multispecific Binding Proteins
Introduction
Wulf-Dirk Leuschner is a notable inventor based in Niedernhausen, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of multispecific binding proteins. With a total of four patents to his name, Leuschner's work has advanced the understanding and application of binding proteins in various therapeutic contexts.
Latest Patents
Leuschner's latest patents include innovative technologies related to multispecific binding proteins. One of his patents describes binding proteins that comprise a variable light (VL) region paired with a variable heavy (VH) region, along with a constant heavy 1 (CH1) region paired with a constant light (CL) region. These proteins feature opposite charged mutations to facilitate pairing, as well as engineered cysteine residues to form disulfide bonds. Another patent focuses on multispecific antibodies, particularly bispecific antibodies, which are modified to ensure desired chain pairing through the use of different dimerization domains for light chain pairing. These advancements are crucial for the development of effective therapeutic agents.
Career Highlights
Wulf-Dirk Leuschner is currently employed at Sanofi, a global healthcare company. His work at Sanofi has allowed him to collaborate with other talented professionals in the field, contributing to groundbreaking research and development in biotechnology. His expertise in binding proteins has positioned him as a key figure in the advancement of therapeutic solutions.
Collaborations
Leuschner has worked alongside notable colleagues such as Christian Beil and Christian Lange. Their collaborative efforts have further enhanced the research and development of innovative binding proteins and antibodies.
Conclusion
Wulf-Dirk Leuschner's contributions to the field of biotechnology, particularly in the area of multispecific binding proteins, have made a significant impact on therapeutic development. His innovative patents and collaborations continue to drive advancements in this important area of research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile